Texas Biomed Celebrates 85 Years of Innovative Biomedical Research and Discovery

Celebrating 85 Years of Biomedical Breakthroughs at Texas Biomed

In 2026, the Texas Biomedical Research Institute proudly commemorates its 85th anniversary, reflecting on a storied history of scientific discovery and innovation. Founded in 1941 by philanthropist Thomas Baker Slick Jr., the institute has steadfastly dedicated itself to eradicating infectious diseases and advancing public health through rigorous biomedical research.

As a premier independent research institution, Texas Biomed has achieved remarkable milestones that have significantly influenced modern medicine. Among these achievements is the development of a high-frequency neonatal ventilator, pivotal for supporting premature infants. The institute also played a crucial role in the creation of the global Hepatitis B vaccine and contributed to the identification and understanding of Hepatitis C, further solidifying its reputation on the world stage.

More recently, Texas Biomed has become a key player in the fight against the COVID-19 pandemic, conducting critical preclinical research for vaccines and therapies. Their work included essential contributions to the Pfizer-BioNTech and Novavax vaccines, as well as Regeneron’s antibody cocktail, which are essential tools in combating the spread of the virus. The institute’s commitment to innovation continues as researchers work tirelessly to advance therapies and vaccines that are saving lives during infectious disease outbreaks across the globe, particularly in Africa.

Texas Biomed's collaborative spirit is another cornerstone of its success. The institute has forged vital partnerships with academic institutions, industry leaders, and government agencies, strengthening public health infrastructure and accelerating scientific progress in the biomedical field. This integrated approach is further enhanced by Texas Biomed's state-of-the-art high-containment laboratory facilities and its status as one of only seven federally funded National Primate Research Centers in the United States.

Charles (Chuck) Urschel Slick, the son of founder Tom Slick and member of the Texas Biomed Board of Trustees, shared his reflections on the institute's legacy. He quoted, "My father believed in science's power for good. When he founded the Institute in 1941, his vision was to build a center that would foster innovation and challenge scientists to seek revolutionary breakthroughs to advance human health. I believe he would be proud of his legacy today—a world-class facility with nearly 500 employees working together to make the world a better place."

In honor of its 85th year, Texas Biomed plans to host a series of special events, including the inauguration of an 18,000-square-foot Animal Health Center. This center will enhance the institute's capacity to conduct innovative research and deepen its impact on global health challenges. Additionally, a fireside chat series will celebrate Texas Biomed's history, its dedicated researchers, and their ongoing work to advance healthcare.

Texas Biomed's journey over the past 85 years is not only a testament to scientific innovation but also to the transformative power of dedicated research in improving human health. As the institution looks forward to the future, it remains committed to tackling the world's most pressing health challenges through continued groundbreaking research and collaboration.

For more information about Texas Biomed and its impact over the decades, visit Texas Biomed website.